3 Earnings Reports That Caught My Attention Last Week: Ciena Corporation (CIEN), Smith & Wesson Holding Corporation (SWHC)

Page 1 of 2

As first-quarter earnings begin to wind down, I can’t help but point out that the majority of earnings reports we’ve covered over the past year have been better than expected. With so many companies reporting during the weeks that comprise earnings season, it’s easy for some earnings reports to fall through the cracks.

Each week for the past year, I’ve taken a look at three companies that could be worth further research after either beating or missing their profit expectations. Today, we’ll take a gander at three more companies that reported earnings last week. They may have slid under your radar, but they deserve a look.

Company Consensus EPS Reported EPS Surprise
Ciena Corporation (NASDAQ:CIEN) ($0.13) $0.12 192%
Smith & Wesson Holding Corporation (NASDAQ:SWHC) $0.23 $0.26 13%
Sarepta Therapeutics Inc (NASDAQ:SRPT) ($0.29) ($2.36) -714%

Source: Yahoo! Finance.

Ciena Corporation (NASDAQ:CIEN)
Earnings time for Ciena, a telecom network equipment provider, is typically when its shareholders retire to their foxholes, don their hard hats, and prepare for the worst. In short, Ciena’s not had the best track record of delivering on its promises of growth. Its just released first-quarter results, however, speak otherwise.

Ciena (CIEN)In a quarter where Wall Street had expected Ciena Corporation (NASDAQ:CIEN) to lose $0.13 per share, it reported a nearly 9% rise in revenue to $453.1 million and a profit of $0.12! At first I was amazed that shareholders weren’t rioting in the streets, but then I realized that a bullish trend was signaled months ago among networking companies when AT&T Inc. (NYSE:T) and Sprint Nextel Corporation (NYSE:S) both signaled their intentions to beef up infrastructure and 4G LTE network spending.

Ciena’s outperformance should have also been a dead giveaway after fiber-optic products maker JDS Uniphase Corp (NASDAQ:JDSU) crushed the Street’s estimates in late January with its second-quarter results. JDS and Ciena Corporation (NASDAQ:CIEN) go together like peanut butter and jelly and rarely does one do well (or poorly for that matter) without the other following. With JDS expanding its operating margin by 210 basis just from its sequential first-quarter, investors should have been expecting a beat here. For future reference, keep an eye on these two peas-in-a-pod if you want to know the true health of the telecom network equipment industry.

Smith & Wesson Holding Corporation (NASDAQ:SWHC)
In the case of Smith & Wesson, there was absolutely no doubt that it was going to fire past Wall Street’s expectations. For the quarter, the gun manufacturer reported a profit of $0.26 per share – or more than triple the $0.08 reported in the year-ago period – as revenue rose 39% to $136.2 million. The logic behind the move in Smith & Wesson and its biggest rival, Sturm, Ruger & Company (NYSE:RGR) is pretty clear-cut: Consumers are concerned that the tragic deaths at Newtown, Conn., will lead to stricter gun control enforcement by the Obama administration – and they’re probably right.

Ultimately, it was Smith & Wesson Holding Corporation (NASDAQ:SWHC)’s guidance that was expected to do the talking given the projected beat; and shareholders took every opportunity to sell the news. Although the company boosted its full-year revenue guidance to $575 million to $580 million, an expected 40% increase over 2012, investors had hoped for an even rosier forecast with the potential for stricter gun controls on the way.

Sturm, Ruger crushed the Street’s estimates in similar fashion, yet analysts are expecting EPS to fall noticeably in 2014 for both gun manufacturers. The amazing run in gun makers just might be coming to an end sooner than anyone had anticipated.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!